Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Vertex Pharmaceuticals Incorporated, 3 years.
Vertex Pharmaceuticals Incorporated
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Vertex Pharmaceuticals Incorporated | Open-market sale | −318 | $423.73 | $134,746 |
| May 1, 2026 | Vertex Pharmaceuticals Incorporated | Grant or award | +943 | — | — |
| Feb 13, 2026 | Vertex Pharmaceuticals Incorporated | Open-market sale | −266 | $500.00 | $133,000 |
| Aug 27, 2025 | Vertex Pharmaceuticals Incorporated | Open-market sale | −266 | $386.69 | $102,860 |
| May 2, 2025 | Vertex Pharmaceuticals Incorporated | Open-market sale | −400 | $505.86 | $202,344 |
| May 1, 2025 | Vertex Pharmaceuticals Incorporated | Grant or award | +796 | — | — |
| Aug 30, 2024 | Vertex Pharmaceuticals Incorporated | Option exercise | +646 | $152.74 | $98,670 |
| Aug 30, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −646 | $500.00 | $323,000 |
| Aug 8, 2024 | Vertex Pharmaceuticals Incorporated | Option exercise | +1,292 | $152.74 | $197,340 |
| Aug 8, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −1,292 | $466.29 | $602,447 |
| May 2, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −467 | $402.95 | $188,178 |
| May 1, 2024 | Vertex Pharmaceuticals Incorporated | Grant or award | +1,001 | — | — |
| Oct 17, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −243 | $375.00 | $91,125 |
| Oct 6, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −242 | $360.00 | $87,120 |
| Aug 9, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −242 | $345.51 | $83,613 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.